BioSpace News Archive

Business

3M Announces Upcoming Investor Event

This event will be webcast live, and a replay will be available on 3M’s Investor Relations website at http://investors.3M.com.

January 2, 2018
·
1 min read
Drug Development

Protalix BioTherapeutics Reports Positive Interim Data from Phase II Clinical Trial of OPRX-106 in Patients With Ulcerative Colitis

The phase II clinical trial is a randomized, open label, 2-arm study of OPRX-106 in patients with active mild to moderate ulcerative colitis.

January 2, 2018
·
6 min read
Status Regarding Novo Nordisk’s Holding of Its Own Shares (31 December 2017)

In the fourth quarter of 2017 a total of 13,925,270 B shares were repurchased.

January 2, 2018
·
1 min read
Business

A&E Medical Board Names Eric Sklar as President and Chief Executive Officer

A&E Medical announced that Eric Sklar has been named Chief Executive Officer, effective immediately.

January 2, 2018
·
2 min read
Biotech Bay

Bay Area’s AEGEA Medical Banks $40M

This financing provides substantial incremental capital to fund AEGEA’s operations while it prepares to launch commercially in the US.

January 2, 2018
·
3 min read
Policy

Kessler Topaz Represents Investors in $290M Total Settlement Recovery Reached with Valeant Pharmaceuticals and Bill Ackman’s Pershing Square Over Insider Trading Claims

In settling the claims, Valeant and Pershing Square agreed to jointly pay a total of $290M for all involved investors.

January 2, 2018
·
2 min read
Business

CONMED Corporation Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer

CONMED Corporation announced that it has appointed Todd W. Garner as Executive Vice President and Chief Financial Officer, effective immediately.

January 2, 2018
·
4 min read
BioMidwest

Mesa Labs Declares Quarterly Dividend - Jan. 2, 2018

The dividend will be payable on March 15, 2018, to shareholders of record at the close of business on February 28, 2018.

January 2, 2018
·
2 min read
ESSA Announces Filing of Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering

ESSA Pharma announces a further update to its previously announced equity offering.

January 2, 2018
·
6 min read
Business

PharmaMar Signs a Commercialization and Distribution License Agreement for Aplidin (plitidepsin) With Megapharm in Israel

PharmaMar has announced today a commercialization and distribution license agreement with Megapharm for the marine-derived anticancer drug Aplidin in Israel and the territory known as the Palestinian Authority.

January 2, 2018
·
1 min read